Immuneering to Present at the 35th Annual Piper Sandler Healthcare Conference
November 20, 2023 16:05 ET
|
Immuneering Corporation
CAMBRIDGE, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop medicines for broad populations of cancer patients...